Related Experiment Video
Updated: Jul 26, 2025

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Challenges in the Long-term Management of Patients With Coccidioidal Meningitis: A Retrospective Analysis of
Geetha Sivasubramanian1, Saurin Kadakia2, Jani M Kim1
1Division of Infectious Disease, University of California, San Francisco, Fresno, California, USA.
Background:
Coccidioidal meningitis (CM) is the most severe form of disseminated coccidioidomycosis. Despite years of clinical experience, it remains a difficult condition to treat, often requiring surgical procedures, such as placement of a ventriculoperitoneal shunt, in addition to lifelong antifungal therapy.
Methods:
We performed a retrospective analysis of patients with CM seen in a large referral center in Central Valley, California, from 2010 to 2020. Data pertinent to CM were collected and analyzed.
Results:
Among 133 patients with CM identified in the 10-year period, nonadherence to antifungal therapy was noted in 43% of patients. Of the 80 patients who underwent ventriculoperitoneal shunt placement for management of intracranial pressure, shunt failure requiring revision surgery occurred in 42 (52.5%). Rehospitalizations due to CM-related reasons occurred in 78 of 133 patients (59%). Twenty-three percent of patients (n = 29) died due to complications from CM, on an average 22 months after the diagnosis of CM. Encephalopathy at presentation was associated with a significantly higher risk of death.
Conclusions:
Patients with CM in central California are predominantly rural agricultural workers with elevated levels of poverty and low health literacy and many barriers to care, leading to high rates of medication nonadherence and loss to follow-up outpatient care. Management challenges are frequent, such as failure of antifungal therapy, high rates of rehospitalization, and the need for repeated shunt revision surgeries. In addition to the development of curative new antifungal agents, understanding the barriers to patient adherence to care and antifungal therapy and identifying means to overcome such barriers are of paramount importance.
Insights
Coccidioidal meningitis (CM) treatment is challenging, with high rates of antifungal nonadherence and shunt failures. Addressing patient barriers to care is crucial for improving outcomes in this severe fungal infection.
Area of Science:
- Infectious Diseases
- Neurology
- Public Health
Background:
- Coccidioidal meningitis (CM) is the most severe form of disseminated coccidioidomycosis.
- Treatment is difficult, often requiring surgery and lifelong antifungal therapy.
Purpose of the Study:
- To analyze treatment outcomes and challenges in Coccidioidal meningitis (CM) patients.
- To identify factors associated with mortality and treatment failure.
Main Methods:
- Retrospective analysis of 133 Coccidioidal meningitis (CM) patients from 2010-2020 in Central Valley, California.
- Data collected on antifungal adherence, surgical interventions, rehospitalizations, and mortality.
Main Results:
- 43% of patients were nonadherent to antifungal therapy.
- 52.5% of shunt placements required revision surgery.
- 23% of patients died, with encephalopathy at presentation increasing mortality risk.
Conclusions:
- CM patients in Central California face socioeconomic barriers impacting adherence and follow-up.
- High rates of treatment failure, rehospitalization, and surgical complications are observed.
- Overcoming barriers to care and developing new antifungal agents are essential for improving CM management.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

